Biomerica signs exclusive distribution agreement in China for its colorectal screening test with total minimum purchase requirement of $17 million over 7 years and an upfront pre-payment of $1 million.
MaxHealth to distribute Biomerica's colorectal screening test to help identify the early warning signs of colorectal cancer.
Please Click Here for Press Release
Safe Harbor Statement